Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term risk stratification with dipyridamole imaging

J Lette1, C Bertrand, D Gossard

  • 1Maisonneuve Hospital, Montréal, Québec, Canada.

American Heart Journal
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of integrating prehabilitation with the Enhanced Recovery After Surgery (ERAS) protocol in Hartmann's procedure.

Irish medical journal·2025
Same author

Gut microbiota influences <i>Plasmodium falciparum</i> malaria susceptibility.

New microbes and new infections·2025
Same author

Inpatient serum amylase testing post-ERCP.

Irish medical journal·2025
Same author

Long-lasting effects of in utero heat stress on subsequent performances of heifers and primiparous cows.

Journal of dairy science·2024
Same author

Retraction Note: Salt in stools is associated with obesity, gut halophilic microbiota and Akkermansia muciniphila depletion in humans.

International journal of obesity (2005)·2024
Same author

Investigating transmission patterns among preterm neonates during an outbreak of necrotizing enterocolitis related to Clostridium butyricum using whole-genome sequencing.

The Journal of hospital infection·2024

Dipyridamole-thallium 201 imaging reliably predicts future cardiac events in patients with coronary disease. This noninvasive test, along with clinical factors, aids in assessing cardiac risk and guiding treatment decisions.

Area of Science:

  • Cardiology
  • Nuclear Medicine Imaging

Background:

  • Dipyridamole myocardial perfusion imaging is used for patients with coronary disease and low exercise tolerance.
  • Predicting future cardiac events is crucial for risk stratification and treatment planning.

Purpose of the Study:

  • To evaluate the reliability of clinical parameters and dipyridamole-thallium 201 imaging in predicting future cardiac events.
  • To assess the utility of quantitative dipyridamole imaging in risk-profile assessment for patients with coronary disease.

Main Methods:

  • A cohort of 753 patients with suspected or known coronary disease underwent clinical assessment and dipyridamole-201TI imaging.
  • Patients were followed for a mean of 15 months, excluding those who underwent revascularization.
  • Backward stepwise logistic regression analysis was used to identify significant predictors of cardiac events.

Related Experiment Videos

Main Results:

  • A quantitative index of jeopardized myocardium from dipyridamole imaging stratified patients into risk groups with event rates from 1% to 89%.
  • Significant predictors of cardiac events included the myocardial jeopardy index (scintigraphy), left ventricular hypertrophy (ECG), and transient left ventricular dilatation (imaging).

Conclusions:

  • Quantitative dipyridamole-201TI imaging is a powerful predictor of future cardiac events in patients with coronary disease and low exercise tolerance.
  • This imaging modality can significantly contribute to risk-profile assessment and treatment strategies for these patients.